Pathology, genetics and cytogenetics of Wilms' tumour - PubMed (original) (raw)
Review
Pathology, genetics and cytogenetics of Wilms' tumour
Reena Md Zin et al. Pathology. 2011 Jun.
Abstract
Wilms' tumour (WT) is an embryonal cancer of childhood and is thought to be derived from embryonic kidney precursor cells. The Knudson two hit model was initially thought to occur in WT, but findings emerging from genetic and cytogenetic studies in the past two decades have implicated several genetic events. Recent techniques in genetic analysis have improved our ability to characterise changes in genes involved in WT which include WT1, CTNNB1, IGF2 and WTX. These genetic events have not only provided insight into the pathobiology of this malignancy, but the recognition of these candidate genes may offer potential targets for novel therapies. In this review, we will provide an overview of the pathological, genetic and cytogenetic characteristics of WT.
Similar articles
- WT1, WTX and CTNNB1 mutation analysis in 43 patients with sporadic Wilms' tumor.
Cardoso LC, De Souza KR, De O Reis AH, Andrade RC, Britto AC Jr, De Lima MA, Dos Santos AC, De Faria PS, Ferman S, Seuánez HN, Vargas FR. Cardoso LC, et al. Oncol Rep. 2013 Jan;29(1):315-20. doi: 10.3892/or.2012.2096. Epub 2012 Oct 19. Oncol Rep. 2013. PMID: 23117548 - Different incidences of epigenetic but not genetic abnormalities between Wilms tumors in Japanese and Caucasian children.
Haruta M, Arai Y, Watanabe N, Fujiwara Y, Honda S, Ohshima J, Kasai F, Nakadate H, Horie H, Okita H, Hata J, Fukuzawa M, Kaneko Y. Haruta M, et al. Cancer Sci. 2012 Jun;103(6):1129-35. doi: 10.1111/j.1349-7006.2012.02269.x. Epub 2012 Apr 19. Cancer Sci. 2012. PMID: 22409817 Free PMC article. - Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changes.
Fukuzawa R, Anaka MR, Heathcott RW, McNoe LA, Morison IM, Perlman EJ, Reeve AE. Fukuzawa R, et al. J Pathol. 2008 Aug;215(4):377-87. doi: 10.1002/path.2366. J Pathol. 2008. PMID: 18484682 - Molecular genetics of Wilms' tumor: insights into normal and abnormal renal development.
Pelletier J. Pelletier J. Can J Oncol. 1994 Apr;4(2):262-72. Can J Oncol. 1994. PMID: 8004410 Review. - Role of the WT1 gene in Wilms' tumour.
Haber DA, Housman DE. Haber DA, et al. Cancer Surv. 1992;12:105-17. Cancer Surv. 1992. PMID: 1322241 Review.
Cited by
- Rare De Novo IGF2 Variant on the Paternal Allele in a Patient With Silver-Russell Syndrome.
Xia CL, Lyu Y, Li C, Li H, Zhang ZT, Yin SW, Mao Y, Li W, Kong LY, Liang B, Jiang HK, Li-Ling J, Liu CX, Wei J. Xia CL, et al. Front Genet. 2019 Nov 15;10:1161. doi: 10.3389/fgene.2019.01161. eCollection 2019. Front Genet. 2019. PMID: 31803239 Free PMC article. - Wnt Signaling in Cancer Stem Cell Biology.
de Sousa E Melo F, Vermeulen L. de Sousa E Melo F, et al. Cancers (Basel). 2016 Jun 27;8(7):60. doi: 10.3390/cancers8070060. Cancers (Basel). 2016. PMID: 27355964 Free PMC article. Review. - Correlations between Histological and Array Comparative Genomic Hybridization Characterizations of Wilms Tumor.
Chiang MR, Kuo CW, Wang WC, Hou TC, Kuo CY, Lu MY, Lai YC. Chiang MR, et al. Pathol Oncol Res. 2019 Jul;25(3):1199-1206. doi: 10.1007/s12253-019-00601-8. Epub 2019 Jan 23. Pathol Oncol Res. 2019. PMID: 30671724 - 2-deoxy-2-((18)F)fluoro-D-glucose positron emission tomography/computed tomography imaging in paediatric oncology.
Freebody J, Wegner EA, Rossleigh MA. Freebody J, et al. World J Radiol. 2014 Oct 28;6(10):741-55. doi: 10.4329/wjr.v6.i10.741. World J Radiol. 2014. PMID: 25349660 Free PMC article. Review. - A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.
Scollon S, Anglin AK, Thomas M, Turner JT, Wolfe Schneider K. Scollon S, et al. J Genet Couns. 2017 Jun;26(3):387-434. doi: 10.1007/s10897-017-0077-8. Epub 2017 Mar 29. J Genet Couns. 2017. PMID: 28357779 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous